Thiotepa cyclophosphamide followed by granulocyte colony-stimulating factor mobilized allogeneic peripheral blood cells in adults with advanced leukemia. [electronic resource]
Producer: 19960909Description: 353-7 p. digitalISSN:- 0006-4971
- Actuarial Analysis
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bone Marrow -- drug effects
- Bone Marrow Diseases -- chemically induced
- Bone Marrow Transplantation
- CD4 Lymphocyte Count
- Cause of Death
- Combined Modality Therapy
- Cyclophosphamide -- administration & dosage
- Feasibility Studies
- Female
- Follow-Up Studies
- Graft Survival
- Graft vs Host Disease -- etiology
- Granulocyte Colony-Stimulating Factor -- adverse effects
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Hematopoietic Stem Cells -- drug effects
- Humans
- Infections -- etiology
- Leukapheresis -- adverse effects
- Leukemia -- blood
- Lymphoma -- blood
- Male
- Middle Aged
- Multiple Myeloma -- blood
- Multiple Organ Failure -- etiology
- Myelodysplastic Syndromes -- blood
- Pilot Projects
- Primary Myelofibrosis -- blood
- Salvage Therapy
- Survival Analysis
- Survival Rate
- Thiotepa -- administration & dosage
- Tissue Donors
- Transplantation, Homologous
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.